Delivery Order SPE2DB22D1106-SPE2DB25FEYV1
Award Date 7/21/25
Potential Completion Date 7/22/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Troop Support Medical awarded a $621 delivery order to Amerisourcebergen Drug Corporation for 100mg tablets of XCOPRI. The firm fixed price order is for 30 tablets of XCOPRI to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unknown location by September 1, 2023. XCOPRI is used to treat partial-onset seizures in adults and appears to have been a pre-negotiated item under the Medical-Surgical Prime Vendor contract vehicle, though...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply the government with XCOPRI 50 MG TABLET 30S. The contract has a firm fixed price and a ceiling value of $1,989.69. It is not a set-aside contract, indicating open competition. The contract is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product XCOPRI 200 MG TABLET 30S. The contract has a ceiling value of $3,858.89 and an ultimate completion date of September 16, 2024. The contract is a Firm Fixed Price type and does not have a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award. The company holds several Indefinite...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of the pharmaceutical product XCOPRI 50 MG TABLET 30S. The contract has a Firm Fixed Price pricing type and a ceiling value of $1,624.01. The period of performance is through May 2, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a large pharmaceutical distributor, for the supply of 4565952797 - XCOPRI 50 MG TABLET 30S. The fixed-price contract has a ceiling value of $1,823.68 and an ultimate completion date of September 27, 2024. It is not a set-aside contract. This order is likely part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, under which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,709.34 firm fixed price contract is for the supply of 30-count tablets of the pharmaceutical product XCOPRI 100 MG. The ultimate completion date is September 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables the DLA to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 50 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $3,536.88 and a performance period ending on June 30, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of XCOPRI 100 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $2,359.50 and a period of performance ending on July 9, 2025. The contract is not set aside and was awarded on an open competition basis. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of XCOPRI 100 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $1,623.99, is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,624 to Amerisourcebergen Drug Corporation to supply 4562001903 XCOPRI 200 MG TABLET 30S. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 31, 2023 in support of the DLA's procurement programs. No subcontractors or set-aside designations were indicated. The delivery order was issued against an existing DLA-wide...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEYV1Delivery Order
4568851854 ! XCOPRI 50 MG TABLET 30S
Posted 7/21/25
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/21/25 |